The aforementioned discussion clarifies that EMP1 can affect tumor cell apoptosis, proliferation, differentiation, and adhesion, and EMT and PI3K/AKT pathways, and therefore, EMP1 may be involved in cisplatin post‐target resistance and off‐target resistance in OC. Here, AKT1 is linked to neoplasm.